Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 28,935 shares at $50.12 ($1.4M) on 2020-02-10, disclosed to the SEC on 2020-02-12.
Open-market sale of $1.4M RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.05 | 677 | $33K | 2.3% |
| 2 | $50.12 | 14,129 | $708K | 48.9% |
| 3 | $50.12 | 14,129 | $708K | 48.9% |
| Total | $50.09 avg | 28,935 | $1.4M | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |